Related Experiment Video
Updated: Dec 30, 2025

A Proximal Culture Method to Study Paracrine Signaling Between Cells
Published on: August 28, 2018
Osthole inhibited cell proliferation and induced cell apoptosis through decreasing CPEB2 expression via up-regulating
Kena Lu1, Jiajing Lin2, Jun Jiang3
1Department of Gynecology, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Guangxi Zhuang Autonomous Region, Nanning City, China.
Abstract:
Objective: Endometrial carcinoma (EC) was the fourth female malignancies in developed countries. Given that the prognosis of EC is extremely poor, it is vital to investigate its pathogenesis and effective therapeutic targets. However, the mechanism of osthole in EC remains unknown.Materials and methods: Firstly, the different doses of osthole (0, 50, 100, and 200 μM) were used to treat the Ishikawa and KLE cells. The cell proliferation, apoptosis, and cell cycle were measured by cell counting kit-8 (CCK-8), Annexin V-FITC/PI, and cell cycle assays. The apoptosis-related protein levels were examined by western blot. The miR-424 levels in Ishikawa and KLE cells were assessed by quantitative RT-PCR (qRT-PCR). Also, the binding of miR-424 and cytoplasmic polyadenylation element binding protein 2 (CEPB2) was detected by the luciferase reporter assay.Results: In this study, the increasing dose of osthole inhibited proliferation and induced apoptosis of Ishikawa and KLE cells. Moreover, the increasing dose of osthole up-regulated miR-424 and down-regulated the expression of CPEB2. CPEB2 was proved to be the target gene of miR-424. Interestingly, the over-expression of CPEB2 could reverse the changes of osthole-induced proliferation and apoptosis of Ishikawa and KLE cells.Conclusions: In summary, we provided first evidences that osthole inhibited proliferation and induced apoptosis through up-regulating miR-424 to inhibit expression of CPEB2 in EC. Our findings indicated that osthole might act as a novel and potential therapeutic agent for the treatment of EC.
Insights
Osthole effectively inhibits endometrial carcinoma (EC) cell proliferation and promotes apoptosis by upregulating miR-424, which downregulates CPEB2 expression. This study suggests osthole as a potential therapeutic agent for EC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Endometrial carcinoma (EC) is a significant cause of cancer-related mortality in women.
- The poor prognosis of EC necessitates the identification of novel therapeutic targets and agents.
- The precise mechanism of osthole's action in EC remains largely unexplored.
Purpose of the Study:
- To investigate the mechanism underlying osthole's effects on endometrial carcinoma cells.
- To determine if osthole influences cell proliferation, apoptosis, and cell cycle.
- To elucidate the role of the miR-424/CPEB2 axis in osthole-mediated EC inhibition.
Main Methods:
- Treatment of Ishikawa and KLE cells with varying doses of osthole.
- Assessment of cell proliferation, apoptosis, and cell cycle.
- Western blot analysis for apoptosis-related proteins.
- Quantitative RT-PCR (qRT-PCR) for miR-424 expression.
- Luciferase reporter assay to confirm miR-424 targeting of CPEB2.
Main Results:
- Osthole significantly inhibited EC cell proliferation and induced apoptosis in a dose-dependent manner.
- Osthole treatment led to increased miR-424 levels and decreased cytoplasmic polyadenylation element binding protein 2 (CPEB2) expression.
- CPEB2 was confirmed as a direct target of miR-424, and its overexpression reversed osthole's effects.
- Osthole's mechanism involves upregulating miR-424 to suppress CPEB2 expression.
Conclusions:
- Osthole demonstrates anti-cancer properties against endometrial carcinoma by modulating the miR-424/CPEB2 pathway.
- The findings highlight osthole as a potential therapeutic candidate for endometrial carcinoma.
- Further research into osthole's clinical efficacy in EC is warranted.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Cell Specific Gene Expression
